Mirae Asset Global ETFs Holdings
TSHA icon

Mirae Asset Global ETFs Holdings’s Taysha Gene Therapies TSHA Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio TSHA Stock Details TSHA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$870K Buy
127,915
+3,185
+3% +$18.8K ﹤0.01% 1704
2026
Q1 		$549K Buy
124,730
+2,091
+2% +$9.72K ﹤0.01% 1845
2025
Q4 		$678K Buy
122,639
+11,615
+10% +$56.4K ﹤0.01% 1732
2025
Q3 		$362K Buy
111,024
+14,481
+15% +$41K ﹤0.01% 2026
2025
Q2 		$223K Sell
96,543
-6,531
-6% -$14.2K ﹤0.01% 2223
2025
Q1 		$143K Sell
103,074
-5,530
-5% -$9.25K ﹤0.01% 2476
2024
Q4 		$188K Buy
108,604
+20,551
+23% +$42.6K ﹤0.01% 2412
2024
Q3 		$177K Buy
+88,053
New +$193K ﹤0.01% 2421

Other funds holding TSHA

ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's TSHA Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Taysha Gene Therapies (TSHA) stake by 2.6% in Q2 2026, buying an estimated $18.8K and bringing the position to 127,915 shares worth $870K. The position accounts for ﹤0.01% of the portfolio, ranked #1704.

Mirae Asset Global ETFs Holdings first reported a position in TSHA in Q3 2024 and has held it in 8 quarters since. 209 funds tracked by Wall St. Rank hold TSHA as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 127,915 shares of Taysha Gene Therapies worth $870K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 3,185 Taysha Gene Therapies shares in Q2 2026, an estimated $18.8K.
  • Taysha Gene Therapies made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1704 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Taysha Gene Therapies in Q3 2024 and has held it in 8 quarters since.
  • 209 funds tracked by Wall St. Rank held Taysha Gene Therapies as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.